Addition of oral minipulse dexamethasone to narrowband ultraviolet B phototherapy and topical steroids helps arrest disease activity in patients with vitiligo

Br J Dermatol. 2019 Jan;180(1):193-194. doi: 10.1111/bjd.17150. Epub 2018 Oct 10.

Authors

A Tovar-Garza¹, J A Hinojosa¹, L S Hynan^{2

3}, A G Pandya¹

Affiliations

¹ Department of Dermatology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9190, U.S.A.
² Department of Clinical Sciences (Biostatistics), University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9190, U.S.A.
³ Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9190, U.S.A.

PMID: 30188576
DOI: 10.1111/bjd.17150

No abstract available

Publication types

Letter

MeSH terms

Administration, Cutaneous
Administration, Oral
Adult
Combined Modality Therapy / methods
Dexamethasone / administration & dosage*
Female
Glucocorticoids / administration & dosage*
Humans
Male
Middle Aged
Pulse Therapy, Drug
Retrospective Studies
Treatment Outcome
Ultraviolet Therapy / methods*
Vitiligo / therapy*

Substances

Glucocorticoids
Dexamethasone